Cargando…
Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5(+) colorectal cancer
In our previous study, ETV5 mediated-angiogenesis was demonstrated to be dependent upon the PDGF-BB/PDGFR-β/Src/STAT3/VEGFA pathway in colorectal cancer (CRC). However, the ability of ETV5 to affect the efficacy of anti-angiogenic therapy in CRC requires further investigation. Gene set enrichment an...
Autores principales: | Feng, Haoran, Liu, Kun, Shen, Xiaonan, Liang, Juyong, Wang, Changgang, Qiu, Weihua, Cheng, Xi, Zhao, Ren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585575/ https://www.ncbi.nlm.nih.gov/pubmed/33099574 http://dx.doi.org/10.1038/s41419-020-03111-7 |
Ejemplares similares
-
Correction: Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5(+) colorectal cancer
por: Feng, Haoran, et al.
Publicado: (2020) -
ETV1 Positively Correlated With Immune Infiltration and Poor Clinical Prognosis in Colorectal Cancer
por: Shen, Xiaonan, et al.
Publicado: (2022) -
Potential Therapeutic Targets of B7 Family in Colorectal Cancer
por: Wang, Changgang, et al.
Publicado: (2020) -
CQ sensitizes human pancreatic cancer cells to gemcitabine through the lysosomal apoptotic pathway via reactive oxygen species
por: Fu, Zhiping, et al.
Publicado: (2018) -
Identification and validation of critical alternative splicing events and splicing factors in gastric cancer progression
por: Feng, Haoran, et al.
Publicado: (2020)